Saturday 17 October 2026
Export TECH’s income statement to Excel — free account
Bio-Techne Corp
TECH Healthcare Biotechnology
Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025. In the quarter to June 2026, revenue grew 1.33%, EPS grew 418.2%, free cash flow fell 6.83% and total debt fell 42.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years.
72.54
0.02
+0.03%
Follow TECH
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
9 | 5 | 4 | 3 | 8 | 6 | 5 | 4 | 7 | 3 |
P/E ratio |
60.38 | 111.85 | 67.56 | 44.85 | 49.95 | 124.04 | 44.01 | 82.72 | 44.38 | 60.27 |
Altman Z-Score |
15.50 | 9.00 | 12.25 | 13.18 | 15.55 | 16.75 | 10.96 | 8.10 | 8.17 | 5.82 |
P/S ratio |
9.07 | 6.65 | 9.74 | 11.29 | 12.30 | 18.74 | 13.66 | 11.07 | 8.64 | 7.79 |
Altman Z″-Score (non-manufacturers) |
8.20 | 5.89 | 6.64 | 6.68 | 6.70 | 5.69 | 5.81 | 4.92 | 5.89 | 4.72 |
P/FCF ratio |
41.86 | 31.59 | 47.83 | 59.36 | 48.49 | 56.67 | 65.73 | 50.62 | 37.18 | 34.11 |
P/Operating CF |
115.48 | 82.53 | 149.59 | 153.86 | 132.35 | 142.98 | 225.23 | 141.33 | 85.68 | 86.24 |
Beneish M-Score |
(2.52) | (3.07) | (2.62) | (2.28) | (2.31) | (2.72) | (2.43) | (2.61) | (2.56) | (2.96) |
Dividend Safety Score |
78 | — | — | — | — | — | — | — | — | — |
P/B ratio |
5.23 | 4.22 | 5.46 | 6.52 | 7.99 | 11.10 | 7.30 | 6.78 | 5.15 | 4.62 |
Price to Tangible BV |
13.29 | 14.16 | 19.17 | 22.95 | 39.13 | 155.50 | 73.99 | 0.00 | 159.46 | 0.00 |
EV/Sales |
9.03 | 6.81 | 9.90 | 11.43 | 12.30 | 18.86 | 13.77 | 11.55 | 8.88 | 8.12 |
EV/EBITDA |
31.40 | 39.13 | 36.03 | 31.98 | 34.21 | 54.01 | 42.36 | 36.67 | 28.47 | 25.31 |
EV/Operating CF |
37.55 | 28.87 | 38.37 | 51.06 | 41.82 | 49.85 | 49.58 | 45.40 | 33.53 | 31.81 |
EV/FCF |
41.66 | 32.36 | 48.59 | 60.09 | 48.52 | 57.03 | 66.29 | 52.79 | 38.23 | 35.56 |
Quick Ratio |
2.94 | 2.10 | 2.47 | 3.29 | 2.51 | 2.48 | 3.69 | 2.98 | 3.80 | 2.03 |
Current Ratio |
4.55 | 3.46 | 3.87 | 4.84 | 3.44 | 3.35 | 4.88 | 4.05 | 5.01 | 2.57 |
Net Debt/EBITDA |
(0.19) | 0.87 | 0.52 | 0.36 | 0.02 | 0.34 | 0.36 | 1.51 | 0.78 | 1.03 |
Debt/Assets |
7.73% | 13.53% | 11.80% | 13.26% | 11.15% | 15.08% | 17.59% | 26.81% | 21.28% | 22.06% |
Debt/Equity |
0.09 | 0.18 | 0.15 | 0.18 | 0.15 | 0.22 | 0.26 | 0.43 | 0.31 | 0.36 |
Asset Turnover |
0.47 | 0.46 | 0.43 | 0.46 | 0.49 | 0.43 | 0.38 | 0.41 | 0.41 | 0.42 |
Operating CF/Net income |
1.61 | 3.92 | 1.78 | 0.89 | 1.20 | 2.51 | 0.90 | 1.89 | 1.35 | 1.89 |
Capex/Depreciation |
(0.30) | (0.28) | (0.56) | (0.36) | (0.44) | (0.50) | (0.63) | (0.33) | (0.32) | (0.25) |
Interest Coverage |
26.16 | 12.02 | 13.13 | 26.66 | 26.23 | 17.01 | 8.20 | 6.76 | 13.37 | 16.38 |
| 9.03% | 3.68% | 8.33% | 15.56% | 16.63% | 9.51% | 18.01% | 8.56% | 12.44% | 8.32% | |
| 7.07% | 2.79% | 6.29% | 11.56% | 11.94% | 6.55% | 11.72% | 5.53% | 8.01% | 5.66% | |
ROIC |
7.70% | 3.04% | 5.78% | 8.85% | 10.84% | 8.82% | 6.71% | 6.09% | 6.88% | 6.64% |
Return on Tangible Assets |
22.38% | 10.82% | 23.70% | 39.67% | 41.68% | 24.80% | 38.79% | 20.68% | 27.18% | 21.89% |
Average Days of Receivables |
65.06 | 61.91 | 76.02 | 70.15 | 64.23 | 57.00 | 60.55 | 70.27 | 68.29 | 75.74 |
Research and Development Expense of Revenue |
7.80% | 8.16% | 8.34% | 8.14% | 7.88% | 7.58% | 8.83% | 8.74% | 8.60% | 9.51% |
Selling, General and Administrative Expense of Revenue |
37.23% | 48.25% | 40.24% | 33.29% | 33.72% | 34.90% | 35.28% | 37.02% | 37.42% | 35.60% |
Intangible Assets out of Total Assets |
0.49 | 0.53 | 0.55 | 0.53 | 0.59 | 0.64 | 0.61 | 0.70 | 0.66 | 0.66 |
Share Based Compensation of Revenue |
3.40% | 3.35% | 3.28% | 3.45% | 3.82% | 5.26% | 4.38% | 4.52% | 4.39% | 2.60% |
Graham Net Nets |
0.02 | 0.00 | 0.00 | 0.00 | 0.00 | (0.01) | (0.01) | (0.04) | (0.02) | (0.06) |
Graham Number |
18.86 | 11.23 | 17.69 | 22.63 | 20.57 | 14.39 | 17.47 | 10.48 | 11.63 | 8.35 |
Earnings Yield |
1.66% | 0.89% | 1.48% | 2.23% | 2.00% | 0.81% | 2.27% | 1.21% | 2.25% | 1.66% |
Free Cash Flow Yield |
2.39% | 3.17% | 2.09% | 1.68% | 2.06% | 1.76% | 1.52% | 1.98% | 2.69% | 2.93% |
Revenue per Share |
7.79 | 7.74 | 7.35 | 7.23 | 7.05 | 6.01 | 4.83 | 4.72 | 4.29 | 3.77 |
Operating CF per Share |
1.87 | 1.83 | 1.90 | 1.62 | 2.07 | 2.27 | 1.34 | 1.20 | 1.14 | 0.96 |
Capex per Share |
(0.18) | (0.20) | (0.40) | (0.24) | (0.29) | (0.29) | (0.34) | (0.17) | (0.14) | (0.10) |
Free Cash Flow per Share |
1.69 | 1.63 | 1.50 | 1.38 | 1.79 | 1.99 | 1.00 | 1.03 | 1.00 | 0.86 |
Cash per Share |
1.70 | 1.03 | 0.97 | 1.30 | 1.57 | 1.49 | 1.77 | 1.10 | 1.21 | 1.06 |
Shareholders Equity per Share |
13.52 | 12.18 | 13.12 | 12.51 | 10.84 | 10.14 | 9.04 | 7.71 | 7.20 | 6.36 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
13.52 | 12.18 | 13.12 | 12.51 | 10.84 | 10.14 | 9.04 | 7.71 | 7.20 | 6.36 |
Free Cash Flow |
263.22 | 256.55 | 236.10 | 216.15 | 280.36 | 307.86 | 153.47 | 156.21 | 149.43 | 128.54 |
Working Capital |
580.70 | 432.45 | 458.04 | 492.97 | 429.54 | 358.32 | 414.25 | 310.62 | 318.86 | 212.50 |
Capital Expenditures |
(28.85) | (31.01) | (62.88) | (38.24) | (44.91) | (44.30) | (51.74) | (25.41) | (20.93) | (15.18) |
Net Current Asset Value |
265.90 | (30.76) | (17.60) | (50.69) | 11.76 | (181.12) | (125.48) | (306.21) | (115.77) | (260.57) |
EV/EBIT |
43.54 | 81.18 | 55.51 | 43.45 | 45.87 | 73.99 | 64.63 | 56.20 | 41.95 | 37.91 |
Capex to Sales |
0.02 | 0.03 | 0.05 | 0.03 | 0.04 | 0.05 | 0.07 | 0.04 | 0.03 | 0.03 |
Price to Operating Income |
43.74 | 79.26 | 54.64 | 42.92 | 45.84 | 73.52 | 64.08 | 53.89 | 40.80 | 36.36 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.42 | 0.45 | 0.44 | 0.47 | 0.45 | 0.42 | 0.47 | 0.51 | 0.44 | 0.44 |
Cash ROIC |
10.23% | 10.57% | 9.29% | 8.57% | 12.72% | 14.36% | 7.64% | 8.50% | 9.34% | 8.86% |
Accounts Receivable Turnover |
5.74 | 5.44 | 5.04 | 5.50 | 6.50 | 6.95 | 5.68 | 5.54 | 5.42 | 5.36 |
Accounts Payable Turnover |
16.00 | 13.57 | 12.23 | 12.32 | 11.04 | 11.36 | 13.00 | 13.88 | 11.94 | 10.05 |
Inventory Turnover |
2.16 | 2.33 | 2.22 | 2.35 | 2.71 | 2.71 | 2.63 | 2.72 | 2.89 | 3.21 |
Average Days of Payables |
23.43 | 21.52 | 35.59 | 25.55 | 35.41 | 35.97 | 32.99 | 24.60 | 31.94 | 32.65 |
Days of Inventory on Hand |
171.76 | 161.05 | 168.50 | 170.76 | 147.55 | 142.91 | 147.36 | 138.18 | 148.26 | 116.50 |
Average Receivables |
211.73 | 224.14 | 229.93 | 206.51 | 169.97 | 133.96 | 130.00 | 128.88 | 118.56 | 105.11 |
Average Payables |
26.01 | 31.64 | 31.82 | 29.77 | 31.62 | 26.24 | 19.65 | 17.33 | 17.65 | 18.75 |
Average Inventory |
192.60 | 184.59 | 175.68 | 156.38 | 128.94 | 109.95 | 97.10 | 88.35 | 72.90 | 58.63 |
Average Assets |
2,572.30 | 2,630.87 | 2,671.28 | 2,466.75 | 2,278.88 | 2,145.27 | 1,956.00 | 1,738.81 | 1,575.71 | 1,343.90 |
Average Common Equity |
2,013.51 | 1,993.83 | 2,017.68 | 1,833.76 | 1,636.12 | 1,476.21 | 1,273.39 | 1,122.33 | 1,014.34 | 914.45 |
Columns are period end dates